Drugs Made In America Acquisition (DMAAR) Cash & Equivalents (2024 - 2025)
Drugs Made In America Acquisition (DMAAR) posted Cash & Equivalents of $6137.0 for Q4 2025, up 755.93% on a QoQ basis from $717.0 in Q3 2025, and up 354.26% year-over-year from $1351.0 in Q4 2024.
Drugs Made In America Acquisition (DMAAR) Cash & Equivalents (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition's Cash & Equivalents history runs 2 years deep, the most recent figure standing at $6137.0 for Q4 2025.
- Quarterly Cash & Equivalents rose 354.26% year-over-year to $6137.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6137.0 (up 354.26% YoY) and the FY2025 annual result came in at $6137.0, up 354.26% from the prior year.
- Cash & Equivalents was $6137.0 for Q4 2025 at Drugs Made In America Acquisition, up from $717.0 in the prior quarter.
- Across five years, Cash & Equivalents topped out at $6137.0 in Q4 2025 and bottomed at $717.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | SIM Acquisition Corp. I | 314.52 Mn | 314.52 Mn | - | 468,399.00 |
| 2 | Thayer Ventures Acquisition | 208.29 Mn | 208.29 Mn | - | - |
| 3 | Newbury Street II Acquisition | 185.26 Mn | 185.26 Mn | - | 497,393.00 |
| 4 | Dynamix | 178.78 Mn | 178.78 Mn | - | 223,698.00 |
| 5 | Hallmark Venture | 103.01 Mn | 102.76 Mn | - | 250,000.00 |
| 6 | Voyager Acquisition | 99.58 Mn | 99.45 Mn | - | 133,831.00 |
| 7 | Gores Holdings X | 95.80 Mn | 95.37 Mn | - | 194,541.00 |
| 8 | Archimedes Tech SPAC Partners | 89.88 Mn | 89.88 Mn | - | 1.36 Mn |
| 9 | Cohen Circle Acquisition | 80.05 Mn | 80.05 Mn | - | 1.46 Mn |
| 10 | Drugs Made In America Acquisition | 1.46 Mn | 1.46 Mn | - | 6,137.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6,137.00 |
| Sep 30, 2025 | 717.00 |
| Jun 30, 2025 | 822.00 |
| Mar 31, 2025 | 923.00 |
| Dec 31, 2024 | 1,351.00 |